ArticleImmunoTargets and therapy2024

Clinical Significance and Molecular Annotation for PD-L1 Negative Advanced Non-Small Cell Lung Cancer with Sensitivity to Responsive to Dual PD-1/CTLA-4 Blockade.

Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.